From January 19, 2024, the Research Center will be moved to Vietcap IQ
toggle icon
logo text
logo symbol
toggle icon

BMI [BUY +23.5%] - Improving combined ratio; cutting financial income - Update

Company Research

05 Sep 2022

- We cut our target price (TP) for BMI by 6.9% to VND36,400/share but maintain a BUY rating.

- Our lower TP reflects (1) our 7.2 % aggregate decrease in 2022-2023F NPAT and (2) a decrease in target P/B from 1.7x to 1.6x.

- Our 7.2% cut in aggregate 2022-2023F net income is mainly due to (1) a 24.9% aggregate decrease in net financial income that outweighs a (2) 30.3% increase in operating profit driven by 1.6 ppt and 0.8 ppt decreases in the 2022F and 2023F combined ratios, respectively.

Powered by Froala Editor

Tags: BMI

Contact us for a research access: (+84) 2 8888 2 6868